Table 2 Rank probability analysis of CRP with using stains in COPD patients
From: Effectiveness of long-term using statins in COPD – a network meta-analysis
Treatment | SUCRA | sd | 2.50% | median | 97.50% |
|---|---|---|---|---|---|
Atorvastatin | 68.0 | 0.1685 | 0.2 | 0.8 | 1.0 |
Fluvastatin | 97.7 | 0.0969 | 0.6 | 1.0 | 1.0 |
Rosuvastatin | 49.3 | 0.2392 | 0.0 | 0.4 | 0.8 |
Pravastatin | 33.9 | 0.2718 | 0.0 | 0.2 | 0.8 |
Simvastatin | 46.3 | 0.1759 | 0.2 | 0.4 | 0.8 |
Conventional treatment | 4.8 | 0.0900 | 0.0 | 0.0 | 0.2 |